Table IV.
Selected studies reporting the treatment and outcome of acute mesenteric venous thrombosis.
| First author | Median study year | N | Mean age (years) | Mean hospital stay (days) | Surgery (%) | Resection (%) | Anticoagulation therapy (%) | Anticoagulant | Mortality (%) | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| Morasch | 1992 | 31 | 49.1 | N/A | 35.5 | 32.3 | 71.0 | UFH | 22.6%a | 30 |
| Alvi | 1996 | 20 | 55.6 | N/A | 40 | 40 | 100 | UFH | 20% | 24 |
| Brunaud | 1997 | 12 | 56.7 | 23.2±8.4 | 8.3 | 8.3 | 100 | UFH | 25.0% | 2 |
| Zhang | 1999 | 28 | 45 | 12.6±4.6 | 32.1 | 17.9 | 100 | UFH+LMWH | 11.0% | 6 |
| Joh | 1999 | 6 | 45 | 31 | 0 | 0 | 100 | UFH or LMWH | 0% | 31 |
| Muñoz | 2000 | 13 | 68 | N/A | 38.5 | N/A | 69.2 | UFH | 38.5%b | 32 |
| Cenedese | 2005 | 9 | 57 | N/A | 55.6 | 55.6 | 100 | N/A | 0% | 33 |
| Present study | 2014 | 18 | 50.9 | 16.4±7.6 | 11.1 | 11.1 | 100 | ARG | 0% | − |
a
The incidence of surgery, bowel resection and mortality only refer to the in-hospital rates.
b
Overall mortality was 22.6%, while the mortality of patients initially treated with heparin was 13.6%.
c
Overall mortality was 38.5%, while the mortality of patients that were initially treated with heparin was 11.1%. N/A, data not available; UFH, unfractionated heparin; LMWH, low molecular weight heparin; ARG, argatroban.